United Health Products, Inc. (UEEC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15K 30K 45K Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 37.5K Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-7K 0 7K 14K 21K Q2 '18: 60 Q3 '18: 5.6K Q1 '19: 0 Q2 '19: 4.4K Q3 '19: 0 Q4 '19: -814 Q1 '20: 186 Q2 '20: 80 Q3 '20: 102 Q4 '20: 80 Q1 '21: 34 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.9K Q4 '22: 0 Q3 '23: 0 Q4 '23: 0 Q3 '18 Q3 '19 Q2 '20 Q1 '21 Q4 '21 Q3 '22 Q4 '23

Operating Income Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -724.4K Q4 '21: -1.1M Q1 '22: -954.5K Q2 '22: -754.8K Q3 '22: -539.2K Q4 '22: -553.6K Q1 '23: -1.1M Q2 '23: -475.5K Q3 '23: -450.5K Q4 '23: -446.7K Q1 '24: -425.1K Q2 '24: -405.2K Q3 '24: -391.9K Q4 '24: -785.4K Q1 '25: -1.5M Q2 '25: -268.4K Q3 '25: -233.2K Q4 '25: -264.7K Q1 '26: -265.6K Q2 '26: -166.8K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -724.4K Q4 '21: -1.5M Q1 '22: -964.3K Q2 '22: -879K Q3 '22: 820.6K Q4 '22: -664.8K Q1 '23: -1.1M Q2 '23: -522.9K Q3 '23: -485.7K Q4 '23: -471.9K Q1 '24: -451.9K Q2 '24: -432K Q3 '24: -303.7K Q4 '24: -814.1K Q1 '25: -1.5M Q2 '25: -315.2K Q3 '25: -285.6K Q4 '25: -536.9K Q1 '26: -315.8K Q2 '26: -284.1K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 30K 60K 90K Q2 '18: 1.8K Q3 '18: 3.5K Q4 '18: 82.6K Q1 '19: 0 Q2 '19: 502 Q3 '19: 0 Q4 '19: 814 Q1 '20: 105 Q2 '20: 56 Q3 '20: 34 Q1 '21: 25 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 18.6K Q4 '22: 0 Q3 '23: 0 Q4 '23: 0 Q3 '18 Q2 '19 Q1 '20 Q1 '21 Q4 '21 Q3 '22 Q4 '23

Operating Cash Flow Quarterly

-750K -500K -250K 0 250K 500K 750K Q3 '21: -194.1K Q4 '21: -370.4K Q1 '22: -195.7K Q2 '22: -203.5K Q3 '22: -2.1K Q4 '22: -218.4K Q1 '23: -548.1K Q2 '23: -471.2K Q3 '23: -604.8K Q4 '23: -576.5K Q1 '24: -405.8K Q2 '24: -287.7K Q3 '24: -319.8K Q4 '24: -181.4K Q1 '25: -274K Q2 '25: -184.7K Q3 '25: -175.2K Q4 '25: -553.1K Q1 '26: -84.3K Q2 '26: -138K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-600K -400K -200K 0 200K 400K 600K Q3 '19: -412.7K Q4 '19: -521K Q3 '20: -281.2K Q4 '20: -154.6K Q3 '21: -194.1K Q4 '21: -370.4K Q3 '19 Q4 '19 Q3 '20 Q4 '20 Q3 '21 Q4 '21

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 100M 200M 300M Q3 '22: 279.7M Q1 '23: 233.3M Q2 '23: 238.3M Q3 '23: 241.5M Q1 '24: 245.8M Q2 '24: 247.7M Q3 '24: 248.6M Q1 '25: 254.6M Q2 '25: 257.1M Q3 '25: 257.8M Q1 '26: 258.7M Q2 '26: 260M Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.24 -0.16 -0.08 0.00 0.08 0.16 0.24 Q1 '19: -0.03 Q2 '19: -0.02 Q3 '19: -0.02 Q4 '19: -0.04 Q1 '20: -0.02 Q2 '20: -0.02 Q3 '20: -0.07 Q4 '20: -0.08 Q1 '21: -0.20 Q2 '21: -0.21 Q3 '21: -0.16 Q2 '24: 0.00 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.02 Q4 '25: -0.01 Q1 '26: 0.00 Q2 '26: 0.00 Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.